SIMILAR MARKET STUDIES
Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2020 - Growth to Hinge on the Success of Personalized Vaccine Following Early Approval in Germany Summary GBI Research, a leading business intelligence provider, has released its latest research report, "Glioblastoma Multiforme Therapeutics in Major Developed Markets to 2020 - Growth to Hinge on ...
June 2014 | $4995 | View Details >>
ICD Research's "Mahindra Satyam: Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, business description, SWOT analysis, key facts, information on products and services, financial ratios, details of locations and subsidiaries, plus information on key news events affecting the company.
November 2011 | $99 | View Details >>
Summary Abide Therapeutics, Inc. (Abide) is a pharmaceutical company that develops innovative therapies, which targets on serine hydrolases. The company offers endocannabinoid system that includes the cannabinoid receptors (CB1 and CB2) for the effects of both marijuana and natural ligands. It develops small-molecule inhibitor of MGLL, ABX-1431, that controls the magnitude ...
July 2016 | $250 | View Details >>
DelveInsight’s, “NS3/4A Protease Inhibitors -Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the NS3/4A Protease Inhibitors . The DelveInsight’s Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. ...
February 2017 | $1250 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research